Gene: CACNA1G

8913
Ca(V)T.1|Cav3.1|NBR13|SCA42
calcium voltage-gated channel subunit alpha1 G
protein-coding
17q21.33
Ensembl:ENSG00000006283 MIM:604065 Vega:OTTHUMG00000162180 UniprotKB:O43497
NG_032024.1
PubMed
0   ANCO-SNPs
ND
2   
NA (AD)  NA (ND)   (Frontal_Cortex)
2.335e-1 (AD)  9.349e-1 (ND)

DNA Methylation

There is no related methylation information for this gene.

Gene Expression in Different Tissues

Temporal and Spatial Expressions (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes average value of the expressions.

Top Co-expressed Genes in Brain-Frontal Cortex (BA9) (GTEx v7)

Top 10 positively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
GRM20.904
PLXNA10.885
SLC30A30.88
KCNK90.875
DAGLA0.873
LINGO10.872
TNFAIP8L10.87
RTN4RL20.87
PKNOX20.87
SLC8A20.869

Top 10 negatively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
HEY2-0.525
COPZ2-0.516
MBNL3-0.514
REST-0.505
AAMDC-0.499
YES1-0.498
PARD3B-0.485
ACAP1-0.48
STON2-0.48
MYOM1-0.476

Drugs/Compounds

ID Drug Name Drug Type CAS Num Status Role
DB11093Calcium CitrateSmall Molecule813-94-5ApprovedTransporter
DB11348Calcium PhosphateSmall Molecule10103-46-5ApprovedTransporter
DB00347TrimethadioneSmall Molecule127-48-0ApprovedTarget
DB00568CinnarizineSmall Molecule298-57-7Approved|InvestigationalTarget
DB00593EthosuximideSmall Molecule77-67-8ApprovedTarget
DB00661VerapamilSmall Molecule52-53-9ApprovedTarget
DB00909ZonisamideSmall Molecule68291-97-4Approved|InvestigationalTarget
DB01388MibefradilSmall Molecule116644-53-2Investigational|WithdrawnTarget
DB04841FlunarizineSmall Molecule52468-60-7ApprovedTarget
DB05246MethsuximideSmall Molecule77-41-8ApprovedTarget
DB09061CannabidiolSmall Molecule13956-29-1Approved|InvestigationalTarget
DB00421SpironolactoneSmall Molecule52-01-7ApprovedTarget
DB09089TrimebutineSmall Molecule39133-31-8ApprovedTarget
DB09231BenidipineSmall Molecule105979-17-7Approved|InvestigationalTarget
DB09238ManidipineSmall Molecule89226-50-6Approved|InvestigationalTarget
ID Drug Name Action PubMed
C5486512-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in decreased expression of CACNA1G mRNA19933214
C5112952,2',4,4'-tetrabromodiphenyl ether"2,2',4,4'-tetrabromodiphenyl ether analog results in decreased expression of CACNA1G mRNA"19095052
C5112952,2',4,4'-tetrabromodiphenyl ether"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of CACNA1G mRNA"29112739
C5112952,2',4,4'-tetrabromodiphenyl ether"ESR1 gene mutant form inhibits the reaction [2,2',4,4'-tetrabromodiphenyl ether results in increased expression of CACNA1G mRNA]"29112739
C0939732-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [telmisartan results in decreased expression of CACNA1G mRNA]19292980
C0230353,4,5,3',4'-pentachlorobiphenyl"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CACNA1G mRNA"28973690
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CACNA1G mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CACNA1G mRNA"27188386
D000082Acetaminophen[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of CACNA1G mRNA25607892
D000111Acetylcysteine[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CACNA1G mRNA22129741
D020106AcrylamideAcrylamide results in decreased expression of CACNA1G mRNA28959563
D000487AllethrinAllethrin inhibits the reaction [CACNA1G protein results in increased transport of Calcium]14634047
D000535Aluminum[APP protein modified form binds to Aluminum] which results in increased expression of CACNA1G mRNA21298039
D000643Ammonium ChlorideAmmonium Chloride affects the expression of CACNA1G mRNA16483693
D003913DextroamphetamineDextroamphetamine results in decreased expression of CACNA1G mRNA16715494
D000726Androgen Antagonists[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of CACNA1G mRNA25607892
D018501Antirheumatic AgentsAntirheumatic Agents results in increased expression of CACNA1G mRNA24449571
D001151ArsenicArsenic affects the methylation of CACNA1G gene25304211
D001280AtrazineAtrazine results in decreased expression of CACNA1G mRNA25929836
D001464BariumCACNA1G mRNA alternative form results in increased transport of Barium11179973
D001464BariumCACNA1G protein results in increased transport of Barium12163980
D001464BariumCerium inhibits the reaction [CACNA1G protein results in increased transport of Barium]12163980
D001464BariumErbium inhibits the reaction [CACNA1G protein results in increased transport of Barium]12163980
D001464BariumGadolinium inhibits the reaction [CACNA1G protein results in increased transport of Barium]12163980
D001464BariumHolmium inhibits the reaction [CACNA1G protein results in increased transport of Barium]12163980
D001464BariumLanthanum inhibits the reaction [CACNA1G protein results in increased transport of Barium]12163980
D001464BariumNeodymium inhibits the reaction [CACNA1G protein results in increased transport of Barium]12163980
D001464BariumScandium inhibits the reaction [CACNA1G protein results in increased transport of Barium]12163980
D001464BariumYtterbium inhibits the reaction [CACNA1G protein results in increased transport of Barium]12163980
D001464BariumYttrium inhibits the reaction [CACNA1G protein results in increased transport of Barium]12163980
D004958Estradiol[Progesterone co-treated with Estradiol] results in decreased expression of CACNA1G mRNA17404688
D004958EstradiolEstradiol results in increased expression of CACNA1G mRNA19484750
D004958EstradiolEstradiol results in increased expression of CACNA1G mRNA20068009
C006780bisphenol Abisphenol A results in decreased expression of CACNA1G mRNA25047013|2768578
C006780bisphenol Abisphenol A results in increased expression of CACNA1G mRNA25958630
C006780bisphenol AESR1 protein affects the reaction [bisphenol A results in increased expression of CACNA1G mRNA]25958630
C006780bisphenol AESR2 protein affects the reaction [bisphenol A results in increased expression of CACNA1G mRNA]25958630
C006780bisphenol A[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of CACNA1G mRNA25607892
C006780bisphenol A[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in increased expression of CACNA1G mRNA25607892
C006780bisphenol Abisphenol A results in decreased expression of CACNA1G mRNA25181051
C006780bisphenol Abisphenol A inhibits the reaction [CACNA1G protein results in increased transport of Calcium]24170242
C038091butylparaben[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of CACNA1G mRNA25607892
C038091butylparaben[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in increased expression of CACNA1G mRNA25607892
D019256Cadmium ChlorideCACNA1G affects the susceptibility to Cadmium Chloride16282520
D002118CalciumCACNA1G protein results in increased transport of Calcium10734232
D002118CalciumCACNG2 protein affects the reaction [CACNA1G protein results in increased transport of Calcium]10734232
D002118CalciumCACNG4 protein affects the reaction [CACNA1G protein results in increased transport of Calcium]10734232
D002118CalciumCACNG5 protein affects the reaction [CACNA1G protein results in increased transport of Calcium]10734232
D002118CalciumAllethrin inhibits the reaction [CACNA1G protein results in increased transport of Calcium]14634047
D002118CalciumCACNA1G protein results in increased transport of Calcium11073957|1463404
D002118Calciumbisphenol A inhibits the reaction [CACNA1G protein results in increased transport of Calcium]24170242
D002118CalciumCACNA1G protein results in increased transport of Calcium24170242
D002563CeriumCerium inhibits the reaction [CACNA1G protein results in increased transport of Barium]12163980
D002794Choline[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of CACNA1G gene20938992
D005576ColforsinMibefradil inhibits the reaction [[Colforsin co-treated with 1-Methyl-3-isobutylxanthine] results in increased activity of CACNA1G protein]17110049
D005576ColforsinNickel inhibits the reaction [[Colforsin co-treated with 1-Methyl-3-isobutylxanthine] results in increased activity of CACNA1G protein]17110049
D003300Copper[Copper co-treated with Dietary Sucrose] results in increased expression of CACNA1G mRNA26033743
D003300CopperCopper deficiency results in increased expression of CACNA1G mRNA26033743
D003471CuprizoneCuprizone results in decreased expression of CACNA1G mRNA27523638
D003609DactinomycinDactinomycin inhibits the reaction [AGT protein results in increased expression of CACNA1G mRNA]19292980
D003630DaunorubicinDaunorubicin results in decreased expression of CACNA1G mRNA26537877|2894005
D003976DiazinonDiazinon results in increased methylation of CACNA1G gene22964155
D003993Dibutyl Phthalate[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNA1G mRNA25607892
D002945CisplatinCisplatin results in decreased expression of CACNA1G mRNA27392435
D003633Dichlorodiphenyl Dichloroethylene[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNA1G mRNA25607892
D019422Dietary Sucrose[Copper co-treated with Dietary Sucrose] results in increased expression of CACNA1G mRNA26033743
D019422Dietary SucroseDietary Sucrose results in increased expression of CACNA1G mRNA26033743
D004051Diethylhexyl Phthalate[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNA1G mRNA25607892
D004052Diethylnitrosamine[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CACNA1G mRNA22129741
D004317DoxorubicinDoxorubicin results in decreased expression of CACNA1G mRNA26537877|2894005
D004365Drugs, Chinese Herbal"Drugs, Chinese Herbal results in increased expression of CACNA1G mRNA"23811387
C118739entinostatentinostat results in increased expression of CACNA1G mRNA27188386
C038939enzacamene[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of CACNA1G mRNA25607892
C038939enzacamene[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in increased expression of CACNA1G mRNA25607892
C109476epoxiconazole[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNA1G mRNA25607892
D004871ErbiumErbium inhibits the reaction [CACNA1G protein results in increased transport of Barium]12163980
D004997Ethinyl EstradiolESR1 gene mutant form inhibits the reaction [Ethinyl Estradiol results in increased expression of CACNA1G mRNA]29112739
D004997Ethinyl EstradiolEthinyl Estradiol affects the expression of CACNA1G mRNA17555576
D004997Ethinyl EstradiolEthinyl Estradiol results in increased expression of CACNA1G mRNA17942748|2911273
D004997Ethinyl Estradiol[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CACNA1G mRNA17942748
D005411Flame RetardantsESR1 gene mutant form inhibits the reaction [Flame Retardants results in increased expression of CACNA1G mRNA]29112739
D005411Flame RetardantsFlame Retardants results in increased expression of CACNA1G mRNA29112739
D005473FluoxetineFluoxetine affects the expression of CACNA1G mRNA21852994
D005492Folic Acid[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of CACNA1G gene20938992
C069837fullerene C60fullerene C60 results in decreased expression of CACNA1G mRNA19167457
D005682GadoliniumGadolinium inhibits the reaction [CACNA1G protein results in increased transport of Barium]12163980
D019833GenisteinGenistein results in increased expression of CACNA1G mRNA24967385
D006695HolmiumHolmium inhibits the reaction [CACNA1G protein results in increased transport of Barium]12163980
C016517indole-3-carbinol[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CACNA1G mRNA22129741
D0150561-Methyl-3-isobutylxanthineMibefradil inhibits the reaction [[Colforsin co-treated with 1-Methyl-3-isobutylxanthine] results in increased activity of CACNA1G protein]17110049
D0150561-Methyl-3-isobutylxanthineNickel inhibits the reaction [[Colforsin co-treated with 1-Methyl-3-isobutylxanthine] results in increased activity of CACNA1G protein]17110049
D007811LanthanumLanthanum inhibits the reaction [CACNA1G protein results in increased transport of Barium]12163980
D008044Linuron[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNA1G mRNA25607892
D017669Mercury CompoundsMercury Compounds affects the activity of CACNA1G protein16326920
D008715Methionine[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of CACNA1G gene20938992
D008748Methylcholanthrene[Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of CACNA1G mRNA23519560
C004925methylmercuric chloridemethylmercuric chloride results in increased expression of CACNA1G mRNA27188386
D008767Methylmercury CompoundsMethylmercury Compounds affects the activity of CACNA1G protein16326920
D008741Methyl MethanesulfonateMethyl Methanesulfonate results in decreased expression of CACNA1G mRNA26011545
D020748MibefradilCACNA1G protein affects the susceptibility to Mibefradil12130671
D020748MibefradilMibefradil inhibits the reaction [[Colforsin co-treated with 1-Methyl-3-isobutylxanthine] results in increased activity of CACNA1G protein]17110049
D008942MitoxantroneMitoxantrone results in decreased expression of CACNA1G mRNA26537877|2894005
D009285NaphthoquinonesNaphthoquinones results in increased expression of CACNA1G mRNA23811387
D009354NeodymiumNeodymium inhibits the reaction [CACNA1G protein results in increased transport of Barium]12163980
D009532NickelNickel inhibits the reaction [[Colforsin co-treated with 1-Methyl-3-isobutylxanthine] results in increased activity of CACNA1G protein]17110049
C118580octylmethoxycinnamate[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of CACNA1G mRNA25607892
C118580octylmethoxycinnamate[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in increased expression of CACNA1G mRNA25607892
C086401pentabromodiphenyl etherpentabromodiphenyl ether analog results in decreased expression of CACNA1G mRNA19095052
C046012pentanalpentanal results in increased expression of CACNA1G mRNA26079696
D011192Potassium DichromatePotassium Dichromate results in increased expression of CACNA1G mRNA23608068
C045362prochloraz[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNA1G mRNA25607892
C035988procymidone[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNA1G mRNA25607892
D011374ProgesteroneProgesterone results in decreased expression of CACNA1G mRNA23012394
D011374Progesterone[Progesterone co-treated with Estradiol] results in decreased expression of CACNA1G mRNA17404688
D011374ProgesteroneProgesterone results in increased expression of CACNA1G mRNA20726854
C005556propionaldehydepropionaldehyde results in increased expression of CACNA1G mRNA26079696
C093642SB 203580SB 203580 inhibits the reaction [telmisartan results in decreased expression of CACNA1G mRNA]19292980
D012538ScandiumScandium inhibits the reaction [CACNA1G protein results in increased transport of Barium]12163980
D012822Silicon DioxideSilicon Dioxide analog results in decreased expression of CACNA1G mRNA25895662
D013629TamoxifenTamoxifen affects the expression of CACNA1G mRNA17555576
C084178telmisartan2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [telmisartan results in decreased expression of CACNA1G mRNA]19292980
C084178telmisartanSB 203580 inhibits the reaction [telmisartan results in decreased expression of CACNA1G mRNA]19292980
C084178telmisartantelmisartan inhibits the reaction [AGT protein results in increased expression of CACNA1G mRNA]19292980
C084178telmisartantelmisartan results in decreased expression of CACNA1G mRNA19292980
C020806tetrabromobisphenol Atetrabromobisphenol A results in decreased expression of CACNA1G mRNA25172293
D013749Tetrachlorodibenzodioxin[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CACNA1G mRNA17942748
D013755Tetradecanoylphorbol Acetate[Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of CACNA1G mRNA23519560
D014028Tobacco Smoke PollutionTobacco Smoke Pollution results in increased expression of CACNA1G mRNA28065790
D014050TolueneToluene results in increased expression of CACNA1G mRNA22967744
C012589trichostatin Atrichostatin A results in increased expression of CACNA1G mRNA24935251|2854253
C005445triphenyl phosphate"ESR1 gene mutant form inhibits the reaction [[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in increased expression of CACNA1G mRNA]"29112739
C005445triphenyl phosphate"[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in increased expression of CACNA1G mRNA"29112739
C016805tris(1,3-dichloro-2-propyl)phosphate"ESR1 gene mutant form inhibits the reaction [[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in increased expression of CACNA1G mRNA]"29112739
C016805tris(1,3-dichloro-2-propyl)phosphate"[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in increased expression of CACNA1G mRNA"29112739
D014317Tritolyl Phosphates"ESR1 gene mutant form inhibits the reaction [[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in increased expression of CACNA1G mRNA]"29112739
D014317Tritolyl Phosphates"[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in increased expression of CACNA1G mRNA"29112739
D014635Valproic Acid"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CACNA1G mRNA"27188386
D014635Valproic AcidValproic Acid affects the expression of CACNA1G mRNA23179753|2597931
D014635Valproic AcidValproic Acid results in increased expression of CACNA1G mRNA19101580|2627250
D001335Vehicle EmissionsVehicle Emissions results in decreased methylation of CACNA1G gene25560391
C025643vinclozolin[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNA1G mRNA25607892
D024483Vitamin K 3Vitamin K 3 affects the expression of CACNA1G mRNA20044591
D015018YtterbiumYtterbium inhibits the reaction [CACNA1G protein results in increased transport of Barium]12163980
D015019YttriumYttrium inhibits the reaction [CACNA1G protein results in increased transport of Barium]12163980

GO/Pathway

GO ID GO Term Qualifier Evidence PubMed
GO:0005245voltage-gated calcium channel activity-IBA21873635  
GO:0005261cation channel activity-IBA21873635  
GO:0008332low voltage-gated calcium channel activity-IBA21873635  
GO:0008332low voltage-gated calcium channel activity-IDA21084288  26456284  26715324  
GO:0086056voltage-gated calcium channel activity involved in AV node cell action potential-ISS-  
GO:0086059voltage-gated calcium channel activity involved SA node cell action potential-ISS-  
GO:0097110scaffold protein binding-IPI21084288  
GO ID GO Term Qualifier Evidence PubMed
GO:0007268chemical synaptic transmission-IEA-  
GO:0010045response to nickel cation-IEA-  
GO:0034765regulation of ion transmembrane transport-IEA-  
GO:0035725sodium ion transmembrane transport-IEA-  
GO:0042391regulation of membrane potential-IDA21084288  
GO:0045956positive regulation of calcium ion-dependent exocytosis-IBA21873635  
GO:0060371regulation of atrial cardiac muscle cell membrane depolarization-IEA-  
GO:0070509calcium ion import-IBA21873635  
GO:0070509calcium ion import-IDA21084288  
GO:0070588calcium ion transmembrane transport-IDA26456284  26715324  
GO:0086002cardiac muscle cell action potential involved in contraction-ISS-  
GO:0086010membrane depolarization during action potential-IBA21873635  
GO:0086015SA node cell action potential-ISS-  
GO:0086016AV node cell action potential-ISS-  
GO:0086018SA node cell to atrial cardiac muscle cell signaling-ISS-  
GO:0086027AV node cell to bundle of His cell signaling-ISS-  
GO:0086045membrane depolarization during AV node cell action potential-ISS-  
GO:0086046membrane depolarization during SA node cell action potential-ISS-  
GO:0086091regulation of heart rate by cardiac conduction-ISS-  
GO ID GO Term Qualifier Evidence PubMed
GO:0005737cytoplasm-IDA26715324  
GO:0005886plasma membrane-IBA21873635  
GO:0005886plasma membrane-IDA26715324  
GO:0005891voltage-gated calcium channel complex-ISS-  
KEGG ID KEGG Term
hsa04010MAPK signaling pathway
hsa04020Calcium signaling pathway
hsa04930Type II diabetes mellitus
Reactome ID Reactome Term Evidence
R-HSA-1266738Developmental BiologyIEA
R-HSA-375165NCAM signaling for neurite out-growthIEA
R-HSA-419037NCAM1 interactionsIEA
R-HSA-422475Axon guidanceIEA

Interactions (STRING v10.5, Interaction Score >= 0.400)

Publications (Co-occurrence of gene symbol strings and ANCO-Dependence terms)

PMID Title (Year) Author Journal
28264723Developmental pathways to adiposity begin before birth and are influenced by genotype, prenatal environment and epigenome. (2017 Mar 7)Lin XBMC Med
23539450Genomic aberrations occurring in subsets of serrated colorectal lesions but not conventional adenomas. (2013 May 1)Burnett-Hartman ANCancer Res